Pancreatic Cancer Research

ResearcherFred Hutch Cancer CenterActive in the last 2 years

Donghui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-7542-0662; OpenAlex author ID A5100336695, A5109510128; NIH RePORTER profile ID 6616172. Sources: OpenAlex.

Their work

Papers
64 (first author 1, last author 20)
Trials
0
Grants
1
Labs led
1
Collaborators
154
Papers, trials and grants by year

2011: 7 papers · 2012: 7 papers · 2013: 2 papers · 2014: 3 papers · 2015: 9 papers · 2016: 3 papers · 2017: 6 papers, 1 grant · 2018: 4 papers · 2019: 4 papers · 2020: 6 papers · 2021: 4 papers · 2022: 4 papers · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper

Papers 50 of 64

  1. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  2. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  3. Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking. Co-author DOI 10.1200/po.23.00355↗
  4. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study. Co-author DOI 10.1002/cam4.5296↗
  5. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  6. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer. Last author DOI 10.1002/ijc.33877↗
  7. A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. Co-author DOI 10.1016/j.xhgg.2021.100078↗
  8. Identification of novel susceptibility methylation loci for pancreatic cancer in a two-phase epigenome-wide association study. Co-author DOI 10.1080/15592294.2022.2026591↗
  9. Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: A Case-Control Study. Co-author DOI 10.1093/jn/nxab372↗
  10. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  11. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  12. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  13. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  14. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Co-author DOI 10.1002/gepi.22348↗
  15. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  16. Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice Co-author DOI 10.1101/2020.12.04.412320↗
  17. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  18. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  19. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  20. Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study. Last author DOI 10.1093/carcin/bgy169↗
  21. Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study. Co-author DOI 10.1093/jn/nxz081↗
  22. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  23. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  24. Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2018.02.012↗
  25. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  26. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis. First author DOI 10.1097/mpa.0000000000000989↗
  27. CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations. Co-author DOI 10.1158/1055-9965.epi-17-1065↗
  28. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. Last author DOI 10.1002/ijc.30762↗
  29. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers. Last author DOI 10.1002/mc.22604↗
  30. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Co-author DOI 10.1158/1078-0432.ccr-17-0001↗
  31. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Last author DOI 10.18632/oncotarget.16451↗
  32. Diabetes, Pancreatogenic Diabetes, and Pancreatic Cancer. Co-author DOI 10.2337/db16-1477↗
  33. A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma. Co-author PMID 28401019↗
  34. RECQ1 A159C Polymorphism Is Associated With Overall Survival of Patients With Resected Pancreatic Cancer: A Replication Study in NRG Oncology Radiation Therapy… Co-author DOI 10.1016/j.ijrobp.2015.10.062↗
  35. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Co-author DOI 10.1097/mpa.0000000000000392↗
  36. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  37. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer. Co-author DOI 10.1002/cam4.513↗
  38. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  39. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  40. Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Last author DOI 10.1038/srep17102↗
  41. Diabetes Associated With Short Survival in Pancreatic Cancer. Last author DOI 10.1200/jco.2014.60.2896↗
  42. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  43. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. Last author DOI 10.1371/journal.pone.0121082↗
  44. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  45. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Co-author PMID 26693076↗
  46. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  47. Genes-environment interactions in obesity- and diabetes-associated pancreatic cancer: a GWAS data analysis. Last author DOI 10.1158/1055-9965.epi-13-0437-t↗
  48. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer. Last author DOI 10.1371/journal.pone.0085942↗
  49. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  50. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗

Grants 1

  1. KRAS Muations in Plasma cfDNA as Predictor to Erolinib Response in Advanced Pancreatic Cancer R21CA202487↗

Closest collaborators

The 25 strongest of 154 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Wei · 7 shared papers, 2012–2024 · strength 0.77
  2. Manal M. Hassan · 9 shared papers, 2011–2022 · strength 0.70
  3. Ping Chang · 10 shared papers, 2011–2022 · strength 0.57
  4. James L. Abbruzzese · 13 shared papers, 2011–2017 · strength 0.55
  5. Huamin Wang · 6 shared papers, 2015–2022 · strength 0.46
  6. Hongwei Tang · 6 shared papers, 2014–2019 · strength 0.44
  7. Paige M. Bracci · 8 shared papers, 2011–2020 · strength 0.43
  8. Carrie R. Daniel · 3 shared papers, 2019–2022 · strength 0.43
  9. Jiali Zheng · 3 shared papers, 2019–2022 · strength 0.43
  10. Gloria M. Petersen · 7 shared papers, 2014–2020 · strength 0.40
  11. Harvey A. Risch · 7 shared papers, 2014–2020 · strength 0.40
  12. Michael James Overman · 1 shared paper, 1 shared grant, 2015–2017 · strength 0.35
  13. Steve Gallinger · 6 shared papers, 2014–2020 · strength 0.35
  14. Tianzhong Yang · 2 shared papers, 2020–2024 · strength 0.33
  15. Hongwei Tang · 7 shared papers, 2011–2020 · strength 0.30
  16. Eric J. Duell · 5 shared papers, 2014–2020 · strength 0.29
  17. Robert C. Kurtz · 4 shared papers, 2016–2020 · strength 0.27
  18. Rachel Ε. Neale · 4 shared papers, 2016–2020 · strength 0.27
  19. Yixiang Mao · 4 shared papers, 2015–2017 · strength 0.25
  20. Xiaoqun Dong · 7 shared papers, 2011–2014 · strength 0.25
  21. Huili Zhu · 1 shared paper, 2024 · strength 0.24
  22. Ryan Sun · 1 shared paper, 2024 · strength 0.24
  23. Rayjean J. Hung · 3 shared papers, 2018–2020 · strength 0.23
  24. Herbert Yu · 4 shared papers, 2016–2020 · strength 0.23
  25. Ghislaine Scélo · 3 shared papers, 2019–2020 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.